Biodegradable mitral annuloplasty for congenital ischemic mitral regurgitation.
An anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is associated with ischemic mitral regurgitation through a combination of papillary muscle ischemia or permanent fibrosis, left ventricular free wall ischemic dyskinesis and left ventricular dilatation. We report the successful management of a 27-month-old girl with ALCAPA and severe mitral regurgitation using a biodegradable mitral annuloplasty ring. It could represent a novel tool for mitral valve repair in ALCAPA-associated ischemic mitral regurgitation.
Myers
P O
PO
Division of Cardiovascular Surgery, Geneva University Hospitals and Medical School, Geneva, Switzerland. patrick.myers@hcuge.ch
Beghetti
M
M
Kalangos
A
A
D020341:Absorbable Implants; D002675:Child, Preschool; D003330:Coronary Vessel Anomalies / Q000150:complications*; D005260:Female; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation*; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery*; D017202:Myocardial Ischemia / Q000209:etiology*; D011474:Prosthesis Design; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014463:Ultrasonography